Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Longitudinal associations between brain structural changes and fatigue in early MS.
Speed of word retrieval in multiple sclerosis.
Changes in functional network centrality underlie cognitive dysfunction and physical disability in multiple sclerosis.
The efficacy and safety of daclizumab and its potential role in the treatment of multiple sclerosis.
The Cytokine GM-CSF Drives the Inflammatory Signature of CCR2(+) Monocytes and Licenses Autoimmunity.
Brain atrophy and lesion load predict long term disability in multiple sclerosis.
High prevalence of sickness absence and disability pension among multiple sclerosis patients: a nationwide population-based study.
Progressive Multifocal Leukoencephalopathy-Associated Mutations in the JC Polyomavirus Capsid Disrupt Lactoseries Tetrasaccharide c Binding.
MS14 Down-regulates Lipocalin2 Expression in Spinal Cord Tissue in an Animal Model of Multiple Sclerosis in female C57BL/6.
Individuals with neurological diseases are at increased risk of fractures within 180 days of admission to long-term care in Ontario.
Co-occurrence of multiple sclerosis and Thomsen's myotonia: a report of two cases.
Correction: Imatinib Ameliorates Neuroinflammation in a Rat Model of Multiple Sclerosis by Enhancing Blood-Brain Barrier Integrity and by Modulating the Peripheral Immune Response.
Oncostatin M protects against demyelination by inducing a protective microglial phenotype.
Hereditary diffuse leukoencephalopathy with spheroids with phenotype of primary progressive multiple sclerosis.
Increased multiple sclerosis relapses related to lower prevalence of pain.
Inhibition of Epidermal Growth Factor Receptor Improves Myelination and Attenuates Tissue Damage of Spinal Cord Injury.
Effects of Single Bouts of Walking Exercise and Yoga on Acute Mood Symptoms in People with Multiple Sclerosis.
Critical role of the Mac1/NOX2 pathway in mediating reactive microgliosis-generated chronic neuroinflammation and progressive neurodegeneration.
Development and validation of cell-based luciferase reporter gene assays for measuring neutralizing anti-drug antibodies against interferon beta.
Ultra-high field MRI: looking through the 'macroscope'
Drugs in clinical development for multiple sclerosis: focusing on anti-CD20 antibodies.
Neuromyelitis optica mimicking intramedullary tumor.
Protein array-based profiling of CSF identifies RBPJ as an autoantigen in multiple sclerosis.
Therapeutic Apheresis in Pediatric Patients with Acute CNS Inflammatory Demyelinating Disease.
Novel advances in the diagnosis and treatment of neuromyelitis optica: is there a need to redefine the gold standard?

Pages